IRDAI Withholds CEO Variable Pay Over EOM Breaches: What the 2026 Glide-Path Crackdown Signals for Commercial Pricing Discipline

For two years the expenses-of-management (EOM) regime felt like a planning exercise. Insurers that had breached the limits filed board-approved glide paths, committed to a path back to compliance by FY26, and carried on. In May 2026 that changed. IRDAI withheld or deferred the performance-linked variable pay of several insurer chief executives for failing to meet EOM targets or to stay on their committed glide paths. The action draws on the IRDAI (Expenses of Management, including Commission, of Insurers) Regulations, 2024, which empower the regulator to hold back variable pay for key management persons when actual EOM exceeds the board-projected business-plan limit by more than 10 per cent.

This matters because it converts an accounting ratio into a personal consequence for the people who sign off on growth budgets. A CEO whose bonus is contingent on staying inside an EOM corridor will manage the corridor, and the fastest lever inside that corridor is acquisition cost. Acquisition cost is, in plain terms, commission and the surrounding spend on distribution. For a commercial broker, the regulator has just tightened the screw on the single largest discretionary number in an insurer's cost base.

For brokers placing manufacturing, retail and property risks, the practical question is not whether EOM enforcement is real (it now demonstrably is) but which of your markets are running hot on the ratio, and how that will shape the terms you are quoted over the next two renewal cycles.

The 2024 regulations replaced the older segment-by-segment caps with a single company-level limit. For a general insurer the overall EOM ceiling is set at 30 per cent of gross written premium in a financial year, with the definition of allowable expenses (commission, operating costs, and certain heads that can be netted off) prescribed in the master circular. Health and life carriers sit under their own slabs. The shift to a company-level cap gave insurers flexibility on where they spend, but it removed the old defence that a particular line was always loss-making on expenses.

The glide path is the bridge. Insurers that exceeded the limit in FY23 were required to file a board-approved plan showing year-on-year reduction back to compliance, with FY26 as the effective outer date by which they were expected to be at, or materially moving toward, the committed levels. The regulator monitors actuals against that plan. Where the gap is large, two things follow: the variable-pay clawback we have now seen, and closer supervisory attention on the next year's business plan.

The arithmetic is unforgiving for high-growth, high-cost insurers. If you grow premium fast in lines that carry heavy acquisition cost, your numerator (expenses) rises faster than the policyholder-friendly version of your denominator. The cleanest way to defend the ratio is to either grow low-cost premium (direct, renewal, group) or to cut the cost of acquiring new commercial business. Both routes run straight through the broker channel.

Allowable-expense definitions matter here too. Some heads can be excluded or phased, so two insurers with similar headline expense ratios can sit very differently against the regulatory cap. A broker reading an insurer's appetite should look at the reported EOM position, not the raw combined ratio, because the published expense number and the regulatory number are not the same thing.

Cost inside an insurer is broadly fixed cost (staff, systems, premises, reinsurance structuring) and variable cost (commission, broker incentives, campaign spend). When a board needs to move the EOM ratio within a single financial year, fixed cost is slow and politically hard to touch. Variable acquisition cost is fast, contractual at the margin, and largely under the chief distribution officer's control. So it goes first.

In the Indian commercial market this typically appears in four forms. First, a quiet trimming of headline commission on competitive, broker-led accounts where the insurer believes it can hold the business on price and service. Second, a tightening of supplementary or contingent payouts (volume overrides, profit-share arrangements, marketing support) that sit alongside the regulated commission. Third, a sharper line between accounts the insurer wants to acquire (where it will still pay) and accounts it is happy to lose (where it will not). Fourth, a push toward lower-cost channels for the business it can move there.

For the broker, the result is a more two-tier market. On a well-run manufacturing or warehousing risk with clean loss experience and good risk information, the insurer still wants the account and the commercial terms hold. On a marginal, loss-affected or heavily shopped risk, the insurer under EOM pressure has a board-sanctioned reason to walk rather than buy the business with commission and a soft rate.

This is not a temporary squeeze that reverses when the cycle turns. The EOM cap is a structural ceiling, and the glide-path enforcement has now shown that breaching it carries a personal cost at the top of the house. Brokers should plan terms and remuneration conversations on the assumption that acquisition cost discipline is the new baseline, not a one-year event.

Not every insurer is in the same position, and the broker who can tell them apart has a real placement advantage. The insurers most likely to ration acquisition spend are those that grew fast in expensive lines, those that already filed a glide path off an FY23 breach, and those whose published expense ratios sit well above the segment norm.

You will not get the board pack, but several public signals are readable. Watch the combined-ratio commentary in insurer results and the management's language on expense control. An insurer talking about "calibrated growth" and "channel-mix optimisation" is usually an insurer managing an EOM corridor. Watch where capacity quietly withdraws: if a market that used to lead on commercial property terms suddenly turns conservative on a renewable account, EOM pressure is a likely driver alongside loss experience.

The lines most exposed to this dynamic are the broker-intermediated commercial classes where acquisition cost is highest relative to premium: mid-market property, package and commercial motor fleet. Personal lines and group health move through different channel economics. On the commercial side, expect the most visible commission and pricing discipline on the accounts that are easiest to shop and hardest to differentiate, because that is exactly where an EOM-pressured insurer has least reason to overpay to win.

The clawback action lands at the same time as the broader push on commission disclosure and reconciliation, and the two reinforce each other. An insurer that must defend its EOM number to the regulator wants every rupee of distribution spend documented, justified and tied to a service it can point to. That changes the tone of the remuneration conversation between insurer and broker.

Expect more insurers to ask what the commission is actually buying. Where a broker delivers genuine work (risk engineering input, claims advocacy, programme design, multi-insurer placement on a hard account) the spend is defensible and survives the EOM lens. Where the relationship is thin and the commission looks like a pure acquisition payment on an easily-placed risk, it is exactly the kind of spend a board trims to protect the ratio. The effort-based commission thinking now in consultation runs in the same direction.

For brokers this is an argument to make your value legible. Document the risk-improvement recommendations you carry to the insurer, the claims you have moved, the survey access you arrange. An insurer can defend paying for that to its own board and to IRDAI. It cannot easily defend paying full freight for a name that adds nothing the direct channel would not.

There is a client-facing dimension too. Corporate risk managers should understand that the terms on the table partly reflect their insurer's EOM position, not only their own loss record. On a tightly-shopped account, pushing every market to the floor on both rate and the broker's remuneration can backfire: it pushes EOM-stretched insurers to decline rather than discount, thinning the panel exactly when the buyer wanted competition. A more deliberate marketing strategy, fewer markets, better information, clearer reasons to win, often produces better terms than a blanket auction.

It is tempting to read EOM enforcement as the trigger for a hard market. That overstates it. EOM constrains the expense side of the equation, not the risk premium. What it does is remove a specific source of soft pricing: the practice of buying commercial market share by accepting a thin or negative underwriting margin and funding the acquisition with commission the insurer cannot really afford.

When that practice is policed, the floor under commercial rates firms up in the most-contested segments. An insurer that cannot win an account by overpaying on acquisition has to win it on rate adequacy and service instead, or let it go. Combined with the de-tariffing correction already pulling fire and engineering minimum rates up through the reinsurance treaty, the EOM discipline reinforces a market where the genuinely underpriced account gets repriced and the well-run account holds.

For commercial buyers the implication is a widening gap between good and poor risks. A manufacturer with strong loss-control, current valuations and clean claims data sits on the right side of every insurer's EOM and underwriting maths, and should still see competitive terms. A buyer relying on a soft market and aggressive broking to mask a deteriorating risk will find that lever gone. The disciplined insurer no longer has the acquisition budget to chase that business at a loss.

The practitioner takeaway is to separate two questions at every renewal. First, is my rate moving because the risk premium is moving (claims, exposure, treaty cost)? Second, is it moving because my insurer can no longer subsidise the account out of acquisition spend? The first is about the risk. The second is about the regulatory squeeze on the insurer, and it is increasingly the part of the renewal story that brokers who understand EOM can explain, and that competitors cannot.

The enforcement signal is most useful if it changes how you prepare. A few concrete moves separate the brokers who get ahead of this from those who are surprised by it.

1. Map your panel by EOM headroom. Classify each insurer as tight, moderate or comfortable on the ratio, using results commentary, growth posture and any glide-path history you can infer. Route easily-placed commercial business toward markets with headroom, and reserve the EOM-tight insurers for accounts where you genuinely differentiate.
2. Make the file defend its own commission. For every meaningful account, document the risk engineering, claims advocacy and placement work that justifies the remuneration. This is your answer when an insurer's EOM review questions distribution spend, and it protects your terms on exactly the accounts most exposed to commission trimming.
3. Recalibrate the marketing strategy on shopped accounts. Resist the instinct to flood every account to fifteen markets. On a tightly-contested risk, a focused approach to a few well-matched insurers with strong information produces better terms than an auction that EOM-stretched markets simply decline to join.
4. Brief clients on the structural shift. Help corporate risk managers see that part of their renewal outcome reflects insurer EOM position and underwriting discipline, not only their own record. That reframing makes a firmer renewal easier to accept and positions you as the adviser who saw it coming.
5. Watch the regulatory next steps. The variable-pay clawback is unlikely to be the last instrument. Track how IRDAI links EOM compliance to business-plan approvals, capital and future product clearances, because each of those tightens insurer appetite further upstream of your placement.

The brokers who treat EOM enforcement as a permanent feature of insurer behaviour, rather than a one-off headline, will read appetite faster, defend their economics better, and give clients a clearer story than competitors still pricing as if the soft-market acquisition game were intact.